Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.

Literature DB >> 6961887

In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins.

Abstract

The comparative in vitro activity of N-formimidoyl thienamycin, cefmetazole, cefoxitin, cefotetan (YM-09330), and moxalactam against 13 isolates of Mycobacterium fortuitum was evaluated by agar dilution susceptibility testing. N-Formimidoyl thienamycin inhibited 10 to 12 strains at 6.25 micrograms/ml, cefmetazole inhibited 12 of 13 strains at 12.5 micrograms/ml, cefoxitin inhibited 11 of 13 strains at 25 micrograms/ml, and cefotetan inhibited 11 of 13 strains at 50 micrograms/ml. Moxalactam was less active than the other compounds tested, inhibiting only 9 of 13 strains at 50 micrograms/ml.

Entities: Chemical Species

Mesh：

Substances：

Year: 1982 PMID： 6961887 PMCID： PMC185727 DOI： 10.1128/AAC.22.6.1079

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

3 in total

Review 1. Description and classification of the newer cephalosporins and their relationships with the established compounds.

Authors: C H O'Callaghan
Journal: J Antimicrob Chemother Date: 1979-11 Impact factor: 5.790

2. Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

Authors: W E Sanders; E C Hartwig; N J Schneider; R Cacciatore; H Valdez
Journal: Antimicrob Agents Chemother Date: 1977-08 Impact factor: 5.191

3. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin.

Authors: M H Cynamon; A Patapow
Journal: Antimicrob Agents Chemother Date: 1981-01 Impact factor: 5.191

3 in total

13 in total

1. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.

Authors: M Casal; F Rodriguez; M Benavente; M Luna
Journal: Eur J Clin Microbiol Date: 1986-08 Impact factor: 3.267

2. Susceptibility of Mycobacterium fallax to imipenem and twenty other antimicrobial agents.

Authors: H Haas; R Zubi; T G Sacks
Journal: Eur J Clin Microbiol Date: 1984-10 Impact factor: 3.267

3. Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.

Authors: R J Wallace; B A Brown; G O Onyi
Journal: Antimicrob Agents Chemother Date: 1991-04 Impact factor: 5.191

Review 4. In vitro activity of imipenem--a review.

Authors: I Braveny
Journal: Eur J Clin Microbiol Date: 1984-10 Impact factor: 3.267

Review 5. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: S P Clissold; P A Todd; D M Campoli-Richards
Journal: Drugs Date: 1987-03 Impact factor: 9.546

6. Beta-lactamase of Mycobacterium fortuitum: kinetics of production and relationship with resistance to beta-lactam antibiotics.

Authors: L Fattorini; G Scardaci; S H Jin; G Amicosante; N Franceschini; A Oratore; G Orefici
Journal: Antimicrob Agents Chemother Date: 1991-09 Impact factor: 5.191

10. In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.

Authors: M H Cynamon; G S Palmer
Journal: Antimicrob Agents Chemother Date: 1983-06 Impact factor: 5.191